This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dolloff, N. G. Articles by Fatatis, A. Search for Related Content PubMed PubMed Citation Articles by Dolloff, N. G. Articles by Fatatis, A.

Human Bone Marrow Activates the Akt Pathway in Metastatic Prostate Cells through Transactivation of the -Platelet–Derived Growth Factor Receptor

¹ Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, Pennsylvania and ² ImClone Systems, Incorporated, New York, New York

Requests for reprints: Alessandro Fatatis, Department of Pharmacology and Physiology, Drexel University College of Medicine, 245 North 15th Street, MS488, New College Building, Philadelphia, PA 19102. Phone: 215-762-8534; Fax: 215-762-2299; E-mail: alessandro.fatatis{at}drexel.edu.

The factors regulating the bone tropism of disseminated prostate cancer cells are still vaguely defined. We report that prostate cancer cells that metastasize to the skeleton respond to human bone marrow with a robust stimulation of the phosphatidylinositol 3-kinase/Akt pathway, whereas prostate cells that lack bone-metastatic potential respond negligibly. The majority of this Akt activation is dependent on -platelet–derived growth factor receptor (-PDGFR) signaling, which was shown using the small-molecule inhibitor of PDGFR signaling AG1296. Low concentrations of PDGF-AA and PDGF-BB found in bone marrow aspirates, which were detected by ELISA, do not account for the high levels of -PDGFR signaling. Additionally, neutralizing PDGF binding using a -PDGFR–specific antibody (IMC-3G3) failed to produce a significant inhibition of bone marrow–induced Akt activation. However, the inhibitory effect of IMC-3G3 rivaled that of AG1296 when incubation was done under conditions that stimulated -PDGFR internalization. We conclude that -PDGFR is activated by multiple soluble factors contained within human bone marrow, in addition to its natural ligands, and this transactivation is dependent on receptor localization to the plasma membrane. Therefore, -PDGFR expression may provide select prostate phenotypes with a growth advantage within the bone microenvironment. [Cancer Res 2007;67(2):555–62]

This article has been cited by other articles:

				H. Lei, G. Velez, P. Hovland, T. Hirose, D. Gilbertson, and A. Kazlauskas Growth Factors Outside the PDGF Family Drive Experimental PVR Invest. Ophthalmol. Vis. Sci., July 1, 2009; 50(7): 3394 - 3403. [Abstract] [Full Text] [PDF]

				H. Lei and A. Kazlauskas Growth Factors Outside of the Platelet-derived Growth Factor (PDGF) Family Employ Reactive Oxygen Species/Src Family Kinases to Activate PDGF Receptor {alpha} and Thereby Promote Proliferation and Survival of Cells J. Biol. Chem., March 6, 2009; 284(10): 6329 - 6336. [Abstract] [Full Text] [PDF]